Target intelligence / Profile preview

Sperm-associated antigen 17 (SPAG17)

Target
SPAG17
Molecular classification
Other (Axonemal central pair apparatus protein, structural protein of cilia/flagella)
01

Overview

Sperm-associated antigen 17 (SPAG17) is a large structural protein (~250 kDa) that is an essential component of the central pair apparatus of axonemal microtubules in cells with 9+2 motile cilia or flagella[2][3][1]. SPAG17 plays a critical role in the proper assembly and function of motile cilia, being crucial for airway mucociliary clearance, normal brain ventricular physiology, and sperm motility[1][2][3][4]. Mutations or knockout of SPAG17 cause loss or impairment of ciliary motility, leading to primary ciliary dyskinesia, male infertility, hydrocephalus, and severe respiratory distress (notably in mice, neonatal lethality occurs within hours due to airway dysfunction)[1][2][3]. SPAG17 is also important for the development and maintenance of skeletal structures, with variants implicated in human height and limb abnormalities[3]. The protein interacts with other central pair proteins such as SPAG6 and SPAG16, and is required for the proper structure of the sperm head and flagellum[2][3][1]. Currently, there are no known small-molecule drugs targeting SPAG17, nor is it a therapeutic target in the sense of druggable receptors or enzymes[3].

Other names
Sperm-associated antigen 17SPAG17FLJ34497PF6RP4-776P7.2CT143Projection protein PF6 homologSPGF55
02

Biological functions

Structural component of the central pair in motile cilia and sperm flagellaRequired for proper function and assembly of cilia and flagellaInvolved in endochondral bone formation (skeletal development)Essential for spermatogenesis and male fertility
03

Disease associations

Primary ciliary dyskinesiaNon-syndromic male infertility (spermatogenic failure, asthenozoospermia)Skeletal malformations (associated with human height, limb defects)
04

Safety considerations

Disruption leads to severe respiratory, neurological, and reproductive deficits in animal models

Beyond the preview

Go deeper on Sperm-associated antigen 17 (SPAG17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sperm-associated antigen 17 (SPAG17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call